144 / 180
300
with previous studies. Eur Heart J. 2011;32:51–60.
10. Savonitto S, Cavallini C, Petronio AS, et al; Italian Elderly ACS
Trial Investigators. Early aggressive versus initially conservative
treatment in elderly patients with non-ST-segment elevation
acute coronary syndrome: a randomized controlled trial. JACC
Cardiovasc Interventions. 2012;5:906–16.
11. Roe MT, Goodman SG, Ohman EM, et al. Elderly patients with
acute coronary syndromes managed without revasculari- zation
insights into the safety of long-term dual antiplatelet therapy
with reduced-dose prasugrel versus standard-dose clopidogrel.
Circulation. 2013;128:823–33.
12. De Luca G, Dirksen MT, Spaulding CS, et al. Impact of age on
long-term outcome after primary angioplasty with bare-metal
or drug-eluting stent (from the DESERT Cooperation). Am J
Cardiol. 2013;112:181–6.
13. Ndrepepa G, Kastrati A, Mehilli J, et al. Age- dependent effect
of abciximab in patients with acute coronary syndromes
treated with percutaneous coronary interventions. Circulation.
2006;114: 2040–6.
14. Clegg A, Young J, Iliff S, Olde Rikkert M, et al. Frailty in elderly
people. Lancet. 2013;381:752–62.
15. Administration on Aging, Administration for Community Living.
A profile of older Americans: 2014. Washington, DC: U.S.
Department of Health and Human Services; 2014.
16. Albert M, McCaig LF, Ashman JJ. Emergency department visits
by persons aged 65 and over: United States, 2009–2010. NCHS
data brief, no 130. Hyattsville (MD): National Center for Health
Statistics; 2013.
17. Jokhadar M, Wenger NK. Review of the treatment of acute
coronary syndrome in elderly patients. Clin Interv Aging
2009;4:435–44.
18. Brieger D, Eagle KA, Goodman SG, et al. Acute coronary syndromes
without chest pain, an underdiagnosed and undertreated high-
risk group: insights from the Global Registry of Acute Coronary
Events. Chest 2004;126:46146–9.
19. Newby L, Jesse RL, Babb JD, et al. ACCF 2012 expert consensus
document on practical clinical considerations in the interpretation
of troponin elevations: a report of the American College of
Cardiology foundation task force on clinical expert consensus
documents. J Am Coll Cardiol 2012;60(23):2427–63.
20. Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid
bedside assay for detection of serum cardiac troponin T. JAMA
1995;273(16):1279–82.
21. Savonitto S., Morici y De Servi S. El tratamiento de síndromes
coronarios agudos de ancianos y pacientes con comorbilidades
Rev Esp Cardiol. 2014;67(7):564–573.
22. Fernández N., Mazoteras V. Y Esquina. Tratado de Medicina
Geriátrica. Fundamentos de la atención Sanitaria a los mayores:
El anciano con cardiopatía isquémica. Capítulo 71, 556-565.
(www.studentconsult.es).
23. Ekerstad N., Swahn E., Janzon M., et al: Frailty Is Independently
Associated With Short-Term Outcomes for Elderly Patients With
Non–ST-Segment Elevation Myocardial Infarction. Circulation
2011; 124: 2397-2404.
24. Purser J.L., Kuchibhatla M.N., Fillenbaum G.G., et al: Identifying
Frailty in Hospitalized Older Adults with Significant Coronary
Artery Disease. J Am Geriatr Soc 2006; 54: 1674-1681.
25. Christiansen EC, Wickstrom KK, Henry TD, et al. Comparison of
functional recovery following percutaneous coronary intervention
for ST elevation myocardial infarction in three age groups (<70,
70 to 79, and
>
80 years). Am J Cardiol. 2013;112:330–335.
26. De Luca G, Dirksen MT, Spaulding CS, et al. Impact of age on
long-term outcome after primary angioplasty with bare-metal
or drug-eluting stent (from the DESERT Cooperation). Am J
Cardiol. 2013;112:181–6.
27. Schiele F, Meneveau N, Seronde MF, Descotes-Genon V, Oettinger
J, Ecarnot F, et al; Reseau de Cardiologie de Franche Comte.
Changes in management of elderly patients with myocardial
infarction. Eur Heart J. 2009;30:987–94.
28. White HD. Thrombolytic therapy in the elderly. Lancet.
2000;356:2028-30.
29. Berkowitz SD, Granger CB, Pieper KS, Lee KL, et al. Incidence and
predictors of bleeding after contemporary thrombolytic therapy
for myocardial infarction. The Global Utilization of Streptokinase
and Tissue Plasminogen activator for Occluded coronary arteries
(GUSTO) I Investigators. Circulation. 1997;95:2508-16.
30. De Servi S, Cavallini C, Dellavalle A, Santoro GM, et al; ROSAI-2
Investigators. Non-ST-elevation acute coronary syndrome in the
el- derly: treatment strategies and 30-day outcome. Am Heart J.
2004;147:830–6.
31. Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos
LA, Anderson HV, et al. The effect of routine, early invasive
management on outcome for elderly patients with non–
ST-segment elevation acute coronary syndromes. Ann Intern
Med. 2004;141:189–95.
[REV. MED. CLIN. CONDES - 2017; 28(2) 291-300]